The cost-effectiveness of antiviral treatment to CHB will be greatly improved with more effective agents emerging and medication cost decreased.

• 随着今后疗效更好的药物的出现和药费的下降，对慢性乙型肝炎患者实施抗病毒治疗将更具成本效果。